chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Large swelling at injection site appeared on 4/15. 4-5 inches at largest point. Very swollen and squishy. Hot  to the touch. Red in color with irregular border. Took antihistamine and acetaminophen at recommendation of CDC website for ?covid arm.? Am worried it could be infection at injection site. Also have some rash/itchiness on both lower legs.
hospitalized 9/8/21 with Acute Hypoxic Respiratory Failure, COVID-19 pneumonia, SARS-CoV-2 positive 9/3/21
This spontaneous report as received from a pharmacist refers to a patient of unknown age. The patient was intramuscularly vaccinated with a dose of 0. 5ml PNEUMOVAX23 (lot # 669579/0595AA) on 12-SEP-2012. The patient was not experiencing any known symptoms. It was unspecified whether the patient had sought medical attention or not. The outcome was unknown. This is one of several reports received from same source. Additional information has been requested.
started with acute symptoms chills, fever, nausea. aches, and after i started to feel better and  then full body rash from my face down my whole body.
Pregnant patient received the second vaccine dose; Chills; achy; headache; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant patient received the second vaccine dose), CHILLS (Chills), MYALGIA (achy) and HEADACHE (headache) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044B21A and 008B21A) for COVID-19 vaccination.     The patient's past medical history included Pregnancy (in Jan 2020 ) in January 2020, Celiac disease, Depression and ADD. Concurrent medical conditions included Allergy to antibiotic (allergy to clindamycin), Gluten sensitive enteropathy (celiac), Grass allergy and Anxiety. Concomitant products included AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL) from 10-Jan-2020 to an unknown date for ADD, BUPROPION from 04-Jan-2020 to an unknown date for Depression and Anxiety, VITAMIN A NOS, PYRIDOXINE HYDROCHLORIDE (B6), CYANOCOBALAMIN (B12-VITAMIIN), VITAMIN C [ASCORBIC ACID], VITAMIN D [VITAMIN D NOS], VITAMIN E NOS, FOLIC ACID (FOLATE), MAGNESIUM, NIACIN, FISH OIL (OMEGA 3 [FISH OIL]) and CALCIUM for an unknown indication, ZINC.   On 01-Apr-2021 at 9:01 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Apr-2021 at 10:30 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was in 2021 and the estimated date of delivery was 01-Nov-2021. On 30-Apr-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant patient received the second vaccine dose), CHILLS (Chills), MYALGIA (achy) and HEADACHE (headache). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) during pregnancy.  On 30-Apr-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant patient received the second vaccine dose) had resolved. On 01-May-2021, CHILLS (Chills), MYALGIA (achy) and HEADACHE (headache) had resolved.            All chromosomal test was performed with no significant findings. No treatment drugs were reported.
This spontaneous report as received from a healthcare worker via field representative refers to a female patient of unknown age. Patient's concurrent conditions and relevant medical history was not reported. On an unknown date the patient was vaccinated with ZOSTAVAX (lot number, dose, frequency and route unspecified). Concomitant medications were not reported. On an unknown date the patient experienced shingles (Herpes zoster) post vaccination. The reporter stated that the patient was not vaccinated at the physician's office where the healthcare worker works. The outcome od shingles was unknown. The causality of the event with zoster vaccine live was not reported, product quality issue was not involved. this case is linked to # 1502USA010983 via same reporter link. Additional information has been requested.
Oblong, irregular pink rash that appears below vaccine site. Tender with palpation. Discomfort at the site of redness. Diffuse ill defined pinkness on the left shoulder.
Information has been received from a physician concerning a 19 year old black female with no pertinent medical history who on 09-MAY-2007 was vaccinated into the deltoid with a first dose of GARDASIL (lot #656051/0244U) Concomitant therapy included ORTHO EVRA. On 16-MAY-2007 the patient experienced urticaria. The patient required 2 emergency room visits. The patient was treated with SOLU-MEDROL, prednisone and BENADRYL. Subsequently, the patient recovered from urticaria. No further information is available.
Right hand fingers that I had tendon transfer to started to pull together about 5 min after the shot, Also my breathing became rapid after walking out of the clinic about 30 min after the shot. Was out of breath doing normal work
Wrong patient was checked in by front desk (same first name as correct patient). RN giving the immunizations did not double check patient birthdate and gave the wrong vaccine to the wrong patient. Patient was not pregnant.
ADMITTED TO HOSPITAL...VENTED IN ICU...TESTED POSITIVE FOR COVID-19
Vaccines were administered at 9am on 9/25/18. At 12am on 9/26/18 patient started having hives all over body. He also complained of right arm pain at the location of the injection.
First shot 2018. Can I still get second; This case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on 20th June 2018).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 18-OCT-2022 Reporter's Comment:  The patient asked, if he/she could still get second shot or did he/she had to start over. Additional Supportive Information: Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination.
Two weeks after second dose I started experiencing dizziness and slight vertigo intermittently throughout the day!
Patient reported confusion, loss of consciousness, appeared to not be breathing, shock-like state, symptoms lasted for about 15 minutes.  This occurred ~12 hours after vaccination, similar event occurred with booster dose.
Redness, Swelling, Hardness, Itchiness at injection site 24+ hours after injection.
Pt. began fever on 5/1, then congestion, runny nose, mild cough, consulted w/renal MD, as she is kidney transplant recipient who advised her to go to ED, tested positive for COVID, all other tests (-), panels/ vitals normal otherwise, received 3 IV doses of remdesivir, recovered well, sent home on 5/5. Pt reports having recv'd Evusheld on April 4th, 2022, intramuscular COVID antibody treatment.
Within a few hours: Sore arm, chills, fever 100.6 for 2 days, joint and muscle aches in arms and legs, weakness, fatigue 2nd day: urgent bowel movement, total clean out, had to stay in bathroom for an hour 3rd day: woke with vertigo/dizziness, felt faint much of day
At approximately 2330 (03/26), I gradually began to feel chills, neck stiffness and soreness, body aches, headaches, and profuse sweating. I took 600 mg of a NSAID at 0900 today (03/27), after waking with the same symptoms in a puddle of sweat.
a little shooting headache every now and then; Dizziness/lightheaded; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 66 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 01Mar2021 08:35 (Lot number: EN6202) at the age of 66 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "high blood pressure" (unspecified if ongoing); "Blood cholesterol increased" (unspecified if ongoing); "low carb diet" (ongoing). Concomitant medication(s) included: LOSARTAN "AGP" taken for hypertension; ATORVASTATIN CALCIUM. The following information was reported: DIZZINESS (non-serious) with onset 01Mar2021, outcome "not recovered", described as "Dizziness/lightheaded"; HEADACHE (non-serious) with onset 02Mar2021, outcome "unknown", described as "a little shooting headache every now and then". Therapeutic measures were not taken as a result of dizziness, headache.  Additional information: Patient was also taking an unspecified over the counter heart burn medication as a concomitant medication. There were no additional vaccines administered on same date of the Pfizer Suspect. Events did not result to physician and emergency room visit. Patient was asking if she needs to see a doctor and if there was any information on low carb diet and the vaccine.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021247362 Same reporter and drug; similar event, different patient.
I've been running a temp for 4 days and my face is very red, mostly my cheeks. I had covid in November and this was my first shot.
Severe weakness; Chills; Fever (~100f); Joint pain; Headache; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 28Mar2021 at 18:00(at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history included amblyopia, blood pressure high and strabismus. Concomitant medications included amlodipine (MANUFACTURER UNKNOWN) for an unknown indication and from an unknown date. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 30Mar2021 at 03:30, the patient experienced chills, fever (~100f), joint pain, headache, severe weakness. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of reported events and included treatment with over-the-counter ibuprofen. The clinical outcomes of the event chills, fever (~100f), joint pain, headache, sever weakness were recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
arm still aches where shot was given can not sleep on this side (left arm) went to heart dr. says not related to heart disease.
Gave 2nd dose vaccination on 14 days instead of 21 days because of error in reading the date of 1st dose
rash, very mild just itching a little bit on right arm just inside the elbow/rash on both arms; took some Benadryl, it helped him sleep; Swelling in eyes; Eyes watering a lot; eyes red, itchy, and swollen/he deduced that he was having an allergic reaction; eyes red, itchy, and swollen/he deduced that he was having an allergic reaction; eyes red, itchy, and swollen/he deduced that he was having an allergic reaction; This is a spontaneous report from a contactable consumer (patient). A 58-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in arm left on 21Jan2021 (Batch/Lot Number: EL9262) as a single dose for COVID-19 immunization. Medical history included cannot see well out of right eye. There were no concomitant medications. Patient had a rash that appeared a couple days after, very mild just itching a little bit on his right arm just inside the elbow. Patient received the vaccine in the opposite arm in the left arm. Patient is going back on 11Feb2021 for the second dose. It was reported that it is better than being on a ventilator. Patient ruled out everything else the rash could have come from, he didn't change his laundry soap, or anything else. He haven't changed anything since he took the vaccine. He didn't speak to his MD about the rash, because he didn't think about it. He is going to be talking to his Doctor on Monday (unspecified date). He is going to get some calamine lotion but he took some Benadryl, it helped him sleep. It was also reported that the patient had a rash on both arms and swelling in his eyes and he went to the eye doctor who has prescribed him some medication and cream from family doctor. He noticed the rash a couple days after the vaccine and the issues with his eyes too, they were also watering a lot, can hardly see out of the right eye, he had this problem prior to vaccination. The cornea specialist prescribed him some drops, that his eyes were red, itchy, and swollen, he deduced that he was having an allergic reaction. Outcome of the event "took some Benadryl, it helped him sleep" was recovering and of the other events was not recovered.  Follow-up attempts are completed. No further information is expected.
Both elbows sore. Right side more Sever. I can barely hold or carry things with right arm.  Joints in both feet sore(Toes). Left side a bit worse.  Pain the same as of now 06/20/2021     I would add that I have no idea if this is due to vaccine. I have never had any issues with my elbows before though  and for both to start hurting simultaneously is odd.    I haven't seen a doctor, I do not have insurance.
Tingling of my mouth and lips.  Blisters in my gum and lips.
5 min. after vaccine, while patient was lying down, he developed red, watery eyes. No rash, no SOB, no itch, he was given BENADRYL 25 mg PO and S/S resolved in 10 minutes.
Had the rabies shot 3 years ago / My antibody titer was 0.1 in the past; This case was reported by a consumer via licensee and described the occurrence of therapeutic response decreased in a female patient who received Rabies NVS (RabAvert) for prophylaxis.   Co-suspect products included rabies vaccine needle device (Rabavert Needle Device) injection needle for an unknown indication, rabies vaccine pre-filled syringe device (Rabavert Pre-Filled Syringe Device) injection syringe for an unknown indication, Rabies NVS (RabAvert) for prophylaxis, rabies vaccine needle device (Rabavert Needle Device) injection needle for prophylaxis, rabies vaccine pre-filled syringe device (Rabavert Pre-Filled Syringe Device) injection syringe for prophylaxis, Rabies NVS (RabAvert) for prophylaxis, rabies vaccine needle device (Rabavert Needle Device) injection needle for prophylaxis, rabies vaccine pre-filled syringe device (Rabavert Pre-Filled Syringe Device) injection syringe for an unknown indication and immunoglobulin human anti-rabies (Hrig) for prophylaxis.   On an unknown date, the patient received the 1st dose of RabAvert, Rabavert Needle Device, Rabavert Pre-Filled Syringe Device, the 2nd dose of RabAvert, Rabavert Needle Device, Rabavert Pre-Filled Syringe Device, the 3rd dose of RabAvert, Rabavert Needle Device, Rabavert Pre-Filled Syringe Device and Hrig at an unknown dose and frequency. On an unknown date, unknown after receiving RabAvert, Rabavert Needle Device, Rabavert Pre-Filled Syringe Device, RabAvert, Rabavert Needle Device, Rabavert Pre-Filled Syringe Device, RabAvert, Rabavert Needle Device and Rabavert Pre-Filled Syringe Device, the patient experienced therapeutic response decreased. On an unknown date, the outcome of the therapeutic response decreased was unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The case was related to pre exposure of Rabavert. The age at vaccination was not reported but the patient was in her 70s. It was reported that the patient had the rabies shot 3 years ago and with that round she got HRIG and Rabavert doses.  The antibody titer was 0.1 in the past. It was reported that many people were not very familiar with this rabies stuff. The patient was not sure if she was protected. For post exposure prophylaxis refer case US2020230715.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020230715:same patient
Dizziness and weakness after 10-15 minutes of vaccination. Unable to carry on walking. Self-treated by sitting down for an hour, then ate a light meal with sugary juice. Symptoms improved after 3-4 hours.
Pain, redness & edema left deltoid within one wk injection. As redness & edema resolved pain radiated to left shoulder neck right shoulder and down both arms. Within 3 wks pain severe, unable to lift right arm independently unable to sleep.  Medical Doctor referred to Neurology.  Prescribed LYRICA & VOLTAREN. Muscle weakness & muscle damage & wasting. Physiotherapy prescribed.
Complained of tingling of tongue and lower lip about 10 minutes after getting the vaccine. Then complained of left thumb tingling. After about 1hr,the tingling had gone. She did receive a Benadryl 25mg at 12:35pm. She was discharged with her son and advised to go to the ER if it got worse again and she had other symptoms. Vitals remained stable.
Got senior delirium syndrome; Very sick; A spontaneous report  was received from a consumer who was also a male patient, unknown age, who received Moderna's COVID-19 Vaccine (mRNA-1273) and experienced senior delirium syndrome(delirium) and was very sick (illness).  The patient's medical history was not provided. Concomitant product use was not provided by the reporter.   On an unspecified date, prior to the onset of the symptoms, the patient received their second of two planned doses of mRNA-1273 (Batch number not provided) intramuscularly for prophylaxis of COVID-19 infection.  On an unspecified date the patient received vaccine and experienced the senior delirium syndrome and patient was very, very, very sick and patient was hospitalized for events. Treatment information was not provided.  Action taken with the drug in response to the events is not applicable as the patient received both scheduled doses of mRNA-1273 prior to the events  The outcome of the events was not reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the events, a causal relationship cannot be excluded.
Immediately after injection - arm ached - soon after injection site swelling up. Next am - arm and hand swelled. Health Dept. personnel notified - 10-21-08. Hot, warm  wet pack applied to (L) arm for 2 days
extreme chills; awful headache; body aches; severe sweating; low oxygen; 102 degree temperature; 120 pulse rate(abnormal for me); my arm felt like it was broken (9/10), but no other problems. Twelve hours later, the pain was still 9/10".; shoulder still sore; This is a spontaneous report from a contactable 58-year-old female consumer reporting for herself  A 58 years old male patient received  first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL3249) on 16Jan2021 at 23:30  at single dose via an unspecified route of administration on right arm for COVID-19 immunization. The patient did not have medical history. Concomitant medications were not reported. The patient reported at inoculation, the injection was high on right arm, and his arm felt like it was broken (9/10), but no other problems. On 17Jan2021 twelve hours later, the pain was still 9/10 so the patient put two heating pads on the site of injection. On the same day (17Jan2021) shortly thereafter, patient also experienced extreme chills, low oxygen (94), 102 degree temperature, 120 pulse rate (abnormal for him), awful headache, body aches, then severe sweating. This peaked 8 hours later and it was gone within 24 hours.  No Treatment was given for the events. At the time of rh reporting the patient informed his shoulder was much better, but still sore.  Patient also informed he was positive for SARS-Cov-2 from 07Dec2020 to 28Dec2020.He had mild symptoms.  The patient recovered with sequel from the events on an unspecified date.
Information has been received from a pharmacy student concerning a 15 year old female who was vaccinated with GARDASIL vaccine (yeast). The patient had knee, elbow and shoulder pain since she was given GARDASIL vaccine (yeast). The reporter did not know how many doses the patient was given. The outcome was unknown. It was unknown if the patient sought medical attention or not. The reporter stated that she was only asked to research the information but was no further information on the patient. No further information is available.
Information has been received from a physician's assistant, concerning a 23 year old female patient, who on approximately 06-MAR-2007 ("three months ago"), was vaccinated with the third dose, 0.5ml, of Gardasil. Following the vaccination (duration not specified), the patient developed raised hives on all of her extremities, but not her trunk. Treatment included prednisone (manufacturer not specified). At the time of this report, the PA indicated the patient had not recovered. Additional information has been requested.
Sore throat; Fever; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Sore throat) and PYREXIA (Fever) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-May-2021, the patient experienced OROPHARYNGEAL PAIN (Sore throat) and PYREXIA (Fever). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. On 29-May-2021, PYREXIA (Fever) had resolved. At the time of the report, OROPHARYNGEAL PAIN (Sore throat) had not resolved.            Concomitant medications were not provided.
lightheadedness, pre-syncopal episode  - resolved after lying flat and resting for 10 minutes occurred after HPV vaccine
PATIENT WAS 13 AT TIME OF VACCINE AND RECEIVED DOSING FOR PEDIATRIC 5-11 PATIENTS. PATIENT WAS INFORMED OF THE ERROR AND WAS TOLD THAT IT IS CONSIDERED BY CDC TO BE SAFE FOR PATIENT TO GET THIS DOSE AND GET THE CORRECT DOSE FOR PATIENTS 12+ FOR THE SECOND DOSE 21 DAYS LATER.
Information has been received from a nurse concerning a 22 year old female patient. The patient's medical history, concurrent condition and concomitant therapy were not provided. The patient was vaccinated with 3 doses of RECOMBIVAX HB (lot #, expiration date and dose not provided) intramuscularly during childhood as following: the first dose on 18-DEC-1993, the second dose on 10-FEB-1994 (inappropriate schedule of vaccine administered) and the third dose on 14-JUN-1994 (inappropriate schedule of vaccine administered). Recently (date unspecified) the patient had titers drawn which resulted as "less than 5" (hepatitis B antibody negative). No treatment was given for the event. The patient sought unspecified medical attention via office visit. The outcome of hepatitis B antibody negative was not resolved. The patient was requesting a second series to be administered (no doses administered as of yet). Additional information has been requested.
J&J vaccine, extremely dizzy, fainting spells, vertigo started on March 26, 2021. Went to ER after reaction becoming worse on April 8, resulting in falling outside in yard. Dr advised going to ER after visit on April 13. Symptoms were stroke and or blood clots. At hospital they took multiple tests but inconclusive if she had a stroke or blood clots. Took CT scan of brain looking for bleeding on the brain. They have all test results. Today still has vertigo, weakness, and fainting spells.